Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8519 |
High Similarity |
NPD6232 |
Discontinued |
0.8481 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8447 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8428 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8373 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8364 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8323 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8313 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8261 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.825 |
Intermediate Similarity |
NPD37 |
Approved |
0.821 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.821 |
Intermediate Similarity |
NPD4966 |
Approved |
0.821 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.821 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8204 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8193 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8193 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8193 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8107 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8095 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7975 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7952 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7925 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7925 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7925 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7904 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7901 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7875 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7829 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7758 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7756 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7748 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7725 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7682 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7677 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7673 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7613 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7607 |
Intermediate Similarity |
NPD5403 |
Approved |
0.76 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD919 |
Approved |
0.7562 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7548 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7547 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7533 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7514 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD447 |
Suspended |
0.75 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7485 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD943 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7421 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7374 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7346 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7341 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7341 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD6746 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.732 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7317 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7312 |
Intermediate Similarity |
NPD6099 |
Approved |
0.731 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7299 |
Intermediate Similarity |
NPD5242 |
Approved |
0.729 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7255 |
Intermediate Similarity |
NPD1283 |
Approved |
0.725 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7211 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7202 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7197 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD3268 |
Approved |
0.719 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD920 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD1933 |
Approved |
0.716 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD1608 |
Approved |
0.712 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7113 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7099 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7093 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7067 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7063 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7059 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7056 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7055 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7053 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7048 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7041 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7037 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.703 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7027
|
Intermediate Similarity |
NPD5283 |
Phase 1 |